Sep 29, 2026 03:30AM
Sep 15, 2026 06:32AM
Sep 15, 2026 06:30AM
Aug 4, 2026 06:30AM
Jul 16, 2026 07:00AM
Jul 9, 2026 07:02AM
Jul 9, 2026 07:00AM Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma
Jun 26, 2026 08:58PM
Apr 14, 2026 07:00AM
Mar 31, 2026 07:00AM
Mar 9, 2026 07:00AM
Feb 27, 2026 03:34PM
Feb 27, 2026 03:32PM
Feb 18, 2026 07:00AM Telo Genomics Closes First Tranche of Convertible Debentures Financing
Jan 29, 2026 08:02AM
Jan 29, 2026 08:00AM
Jan 19, 2026 08:02AM
Jan 19, 2026 08:00AM
Dec 18, 2025 04:05PM
Dec 11, 2025 04:00PM
Nov 13, 2025 08:30AM Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025
Oct 9, 2025 08:30AM
Sep 30, 2025 04:30PM
Sep 19, 2025 08:30AM
Sep 8, 2025 04:20PM
Jul 24, 2025 08:30AM
Jun 30, 2025 06:48PM
Jun 18, 2025 08:30AM Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma
May 27, 2025 08:30AM
May 15, 2025 08:30AM
Apr 10, 2025 08:30AM
Apr 4, 2025 08:30AM
Mar 12, 2025 08:30AM
Feb 27, 2025 08:30AM
Dec 23, 2024 04:00PM Telo Genomics Closes Oversubscribed $2.5 Million Private Placement
Dec 12, 2024 08:45AM
Nov 19, 2024 08:45AM
Oct 30, 2024 08:45AM
Oct 22, 2024 08:45AM
Sep 10, 2024 08:45AM
Aug 13, 2024 08:45AM
Jun 18, 2024 08:45AM Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP
Jun 12, 2024 08:45AM

473,048 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All